Government News

Join WhatsApp Channel

- Read more about No legal action taken on ADR reporter, clarified by IPC
Indian Pharmacopoiea commission (IPC) informed that there will be no legal action taken on Adverse drug reaction (ADR) reporter. And active participation in ADR reporting is needed from all healthcare professionals, as IPC concern.
- Read more about Maharashtra Registered Pharmacists Association working for welfare of Pharmacists and pharma professional
With an aim to promote patient safety by ensuring presence of pharmacists in healthcare delivery of the state, the Maharashtra Registered Pharmacists Association (MRPA) has demanded the implementation of Pharmacy Practice Regulations (PPR) 2015. MRPA submitted a memorandum to Maharashtra Department of Medical Education and Research (DMER) Minister Girish Mahajan in this regards governing Maharashtra State Pharmacy Council (MSPC) which is responsible for implementation of PPR 2015.
- Read more about MTaI protest decision of DoP to bring Stents under DPCO
By protesting the decision of Department of Pharmaceuticals (DoP) to consider Coronary stents in DPCO 2013, Medical Technology Association of India (MtaI) has requested the government to have a holistic view on the decision by involving all the concerned stakeholders i.e. hospitals, physicians, companies in the discussion on price regulations to arrive at a decision which is best for patient health. MTaI also requested to create a vibrant environment for the medical device sector to make innovative therapies accessible to patients and uphold & strengthen the state of healthcare already achieved in the country.

[adsense:336x280:8701650588]
- Read more about Coronary Stents to be included in DPCO: DoP
Department of Pharmaceuticals (DoP) notified that "Coronary Stents" will be included in Drugs Price Control Order (DPCO), soon. This Order may be called the Drugs (Prices Control) third amendment Order, 2016.
- Read more about D&C rules being amended to prohibit misleading advertisements of Ayurveda, Siddha & Unani Drugs : Ayush
Government is aware of the sale and advertisement of Ayurvedic medicines through TV channels which are required to adhere to the Advertising Code prescribed under the Cable TV Networks (Regulation) Act, 1995 and Rules framed thereunder. Presently, there are no regulatory provisions for pre-censorship on advertisements. Action is taken whenever violation of Advertisement Code is brought to the notice of the Ministry of Information and Broadcasting or the advertisement is found to be in contravention of the provisions of Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder.
- Read more about Recent charges of price collusion among generic drug manufacturers to have serious implications: ICRA
As a step-up to the ongoing probe by the anti-trust department of the US Department of Justice (DoJ), initiated in October 2014, on the sharp increases in prices of certain generic drugs in the US and the possibility of cartelisation among the drug makers, 20 US States filed a lawsuit on December 15, 2016 against six pharmaceutical companies – Aurobindo Pharmaceuticals Limited, Citron Pharma LLC, Heritage Pharmaceuticals Inc., Mayne Pharma, Mylan NV and Teva Pharmaceuticals. The lawsuit alleges these companies for conspiring the prices of two generic drugs –Doxycycline Hyclate (an anti-biotic) and Glyburide (an anti-diabetic drug).
- Read more about 68th IPC inaugurated at Andhra University with positive pharma environment
68^th Indian Pharmaceutical Congress (IPC) is organised and started at city of happening, Visakhapatnam under the premises of Andhra University. More than 9000 delegates and students from various part of India participated in this event. This event is organised in Andhra University for three days, 16^th to 18^th December 2016. The main theme of the event is Quality pharmaceuticals & patients welfare.
- Read more about Directorate General of Health Services decided to abolish practice of prior joint inspection for issuance of Form 29 licenses
CDSCO decided to abolish practice of pre-inspection by State Licensing Authority & Central Licensing Authority for issuing Form 29 License to manufacture drugs for purposes of examination, test or analysis for biological products (Vaccines & r-DNA products).

[adsense:336x280:8701650588]
- Read more about Healthcare Sector is moving towards a cashless economy by adopting digital payment
Government of India has taken a series of steps as part of its 'Digital India' initiative. In pursuance of this, the Ministry of Health and Family Welfare has also been making efforts to leverage Information and Communication Technology for improving efficiency and effectiveness of the healthcare delivery in the country.
- Read more about Bombay HC rejects petition of Sun Pharma for ceiling price of ciprofloxacin
Hon’ble Bombay high court rejects petition of Sun Pharmaceuticals Industries Ltd. filed against price fixing of Ciprofloxacin HCL Tablet 250 mg by National Pharmaceutical Pricing Authority (NPPA). Sun Pharma filed petition under paragraph 31 of the Drugs (Prices Control) Order, 2013 against notification S.O. No.1882(E) dated 13.07.2015 issued by the NPPA fixing the ceiling price of Ciprofloxacin.